Please note that the details of this Challenge are no longer open. This challenge is awarded and is no longer accepting new submissions. You can:
Challenge Conquer Paralysis Now Challenge – Trial & Error Prize
Conquer Paralysis Now Challenge – Trial & Error Prize
STATUS: Awarded
Posted: Dec 01 2014
Challenge ID: 9933687
Share Challenge Share

The current spinal cord injury (SCI) research community tend to publish scientific studies with ‘significant’ results and not studies that seem uneventful. Nevertheless, we can learn as much from ‘negative’ results as we can from ‘positive’ ones. Lessons learned from research help to minimize the duplication of experiments and narrow down pathways of innovation. It may also lead to the generation of novel ideas to tackle the same problem. The goal of this platform is to foster the publication of research in an easily accessible format, which scientists would have been hesitant to reveal in normal circumstances. This will help ensure that the total amount of money allocated to SCI research, both inside and outside the Challenge Program, is more efficiently spent. The prize will also provide a good forum to facilitate improved information-sharing and collaboration, as researchers will be able to review and comment on each other’s research.

After a 6-month period, to allow users enough time to register and come to terms with the Trial & Error concept, the top publication from each quarter will receive $1,500, the second $1,000 and the third $500.



Thomas Edison tried two thousand different materials in search of a filament for the light bulb. When none worked satisfactorily, his assistant complained, “All our work is in vain. We have learned nothing.” Edison replied very confidently, “Oh, we have come a long way and we have learned a lot. We know that there are two thousand elements which we cannot use to make a good light bulb.”

The Conquer Paralysis Now (CPN) Challenge aims to accelerate the development of treatments for spinal cord injury (SCI) in order to provide significant improvements in patients’ quality of life. The Trial & Error Prize will run throughout the 10 year Challenge Program, and its aim is to limit the duplication of experiments and create pathways of innovation.

We ask that all Trial & Error Prize submissions be published on ResearchGate (RG) so that fellow researchers have the opportunity to learn from each other and judge each other’s entries. Your entry must be a RG publication and not a PDF, Word document or any other format. This is to ensure all entries can be openly reviewed by fellow SCI researchers and those in adjacent fields.

The finalists for this Prize will be decided by researchers on RG using a crowdvoting system and these judging criteria. All entries must also meet our entry criteria.

To enter, please email with a link to your ResearchGate publication, a short abstract, and confirmation of the authors’ names, institutions/organizations and laboratory, if applicable.

What is InnoCentive?
InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.

What is an InnoCentive Ideation™ Challenge?

An InnoCentive Ideation™ Challenge is a broad question formulated to obtain access to new ideas, similar to a global brainstorm for producing a breakthrough idea or market survey which may include ideas for a new product line, a new commercial application for a current product, or even a viral marketing idea to recruit new customers. Ideation™ Challenge submissions are typically about two written pages, and Seekers receive a non-exclusive, perpetual license to use all submissions.

In an Ideation™ Challenge, Solvers may:

  • Submit ideas of their own
  • Submit third party information that they have the right to use and further the authority to convey that right and the right to use and develop derivative works to Seekers
  • Submit information considered in the public domain without any limitations on use

Solvers should not reveal any confidential information in their submissions. Often the Ideation™ Challenge will be followed by one or more of the other three Challenge types to further develop the ideas and gain Intellectual Property protection when the concept has been well-defined.

Share This Challenge